Literature DB >> 11292288

CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection.

M W Delfs1, Y Furukawa, R N Mitchell, A H Lichtman.   

Abstract

BACKGROUND: CD4+ T cell effector function is sufficient to mediate allograft rejection, and it is suggested that CD8+ T cell-mediated effects are dependent on CD4+ T cell help. CD8+ T cells can be classified into at least two functional subsets: Tc1, producing high amounts of interferon (IFN)-gamma and Tc2, producing interleukin (IL)-4, -5, -10, and -13 and low levels of IFN-gamma. Because these subsets express different chemokine receptors, they may have different capabilities of migrating into grafts. Once in the graft, each subset may perform different effector functions dependent on the cytokines it produces. We asked whether allospecific CD8+ T cells, in the absence of CD4+ T cells, are capable of mediating rejection of a primarily vascularized allograft, and if Tcl and Tc2 cells differ in their ability to mediate rejection.
METHODS: Hearts from H-2d mice were transplanted into H-2b RAG 1-/- recipients. Without manipulation, these fully mismatched allografts would survive indefinitely due to the absence of mature T and B cells. We adoptively transferred allo-(H-2d)-reactive Tcl or Tc2 cells from H-2b mice into each recipient. Grafts were harvested and analyzed on predefined timepoints, rejection was graded on a modified ISHLT scale.
RESULTS: On day 7, grafts from Tc1- or Tc2-injected animals showed grade 1-2 parenchymal rejection with stable phenotype and comparable distribution of graft infiltrating CD8+ T cells. Adoptive transfer of IFN-gammahigh Tc1, but not of IFN-gammalow Tc2 cells was followed by the development of graft vasculitis, as well as graft arteriopathy. Adoptive transfer of IL-4high IL-5high Tc2, but not of IL-4low IL-5low Tc1 cells lead to extensive infiltration of eosinophils and formation of giant cells.
CONCLUSIONS: Both Tc1 and Tc2 cells can mediate murine cardiac allograft rejection in the absence of CD4+ T cell help, although each subset elicits a different type of inflammatory response. In this model, cytokine secretion of either functional CD8+ T effector cell subset is an important effector mechanism in the process of allograft rejection: IFN-gammahigh Tc1 cells are important in early graft vasculitis, although IL-4high IL-5high Tc2 cells promote recruitment of secondary effectors like eosinophils.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292288     DOI: 10.1097/00007890-200103150-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Lymphatic injury and regeneration in cardiac allografts.

Authors:  Thing Rinda Soong; Arvind P Pathak; Hiroshi Asano; Karen Fox-Talbot; William M Baldwin
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

2.  IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

Authors:  Nir Grabie; Michael W Delfs; Jason R Westrich; Victoria A Love; George Stavrakis; Ferhaan Ahmad; Christine E Seidman; Jonathan G Seidman; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Host-based Th2 cell therapy for prolongation of cardiac allograft viability.

Authors:  Shoba Amarnath; Hao Chen; Jason E Foley; Carliann M Costanzo; Joel D Sennesh; Michael A Solomon; Daniel H Fowler
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

4.  A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.

Authors:  Xueli Yuan; Jesus Paez-Cortez; Isabela Schmitt-Knosalla; Francesca D'Addio; Bechara Mfarrej; Michela Donnarumma; Antje Habicht; Michael R Clarkson; John Iacomini; Laurie H Glimcher; Mohamed H Sayegh; M Javeed Ansari
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

5.  The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart Allografts.

Authors:  Johannes Baur; Christoph Otto; Ulrich Steger; Stefan Klein-Hessling; Khalid Muhammad; Tobias Pusch; Krisna Murti; Rhoda Wismer; Christoph-Thomas Germer; Ingo Klein; Nora Müller; Edgar Serfling; Andris Avots
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

6.  Investigation of hub genes and immune status in heart transplant rejection using endomyocardial biopsies.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Wen-Jun Wang
Journal:  J Cell Mol Med       Date:  2020-11-23       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.